Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs11076654 | chr16:90074085 | A/T | 3.58E-6 | 178 | 25.6 | 25 | 4.67 | KM Plot |
PCPG | rs11076663 | chr16:90121131 | A/C | 9.9E-9 | 175 | 25.87 | 20.2 | 6.62 | KM Plot |
PCPG | rs11079995 | chr17:50315044 | C/T | 6.48E-5 | 177 | 25.4 | 28.47 | 14.47 | KM Plot |
PCPG | rs1108063 | chr16:89893983 | A/G | 5.09E-5 | 171 | 26.57 | 20.28 | 36.37 | KM Plot |
PCPG | rs1108189 | chr2:107248650 | T/G | 0.000212 | 178 | 26.57 | 21.95 | 25.87 | KM Plot |
PCPG | rs11088247 | chr21:34603249 | C/G | 9.43E-8 | 178 | 17.22 | 34.37 | 24.1 | KM Plot |
PCPG | rs11088343 | chr21:37635652 | C/T | 0 | 178 | 25.4 | 25.43 | 3.17 | KM Plot |
PCPG | rs1108966 | chr21:38470120 | G/A | 9.32E-9 | 176 | 25.17 | 25.87 | 3.83 | KM Plot |
PCPG | rs11101085 | chr10:50522287 | A/G | 4.68E-6 | 178 | 24.53 | 31.42 | 25.17 | KM Plot |
PCPG | rs11101086 | chr10:50527064 | T/C | 3.71E-6 | 175 | 24.53 | 35.5 | 25.17 | KM Plot |
PCPG | rs11101115 | chr10:50579080 | C/G | 3.87E-6 | 178 | 24.53 | 33.13 | 25.17 | KM Plot |
PCPG | rs11123452 | chr2:118557594 | C/G | 1.77E-5 | 177 | 25.28 | 25.97 | 11.65 | KM Plot |
PCPG | rs11124124 | chr2:107229856 | T/A | 0.000239 | 176 | 26.57 | 23.53 | 25.87 | KM Plot |
PCPG | rs111260190 | chr16:1768133 | T/C | 2.08E-11 | 173 | 25.6 | 18.2 | 4.52 | KM Plot |
PCPG | rs111266578 | chr13:114180121 | A/G | 4.67E-12 | 177 | 24.17 | 30.33 | 3.32 | KM Plot |